Should the fluid from a hydrosalpinx be aspirated?

Hydrosalpinx Management: Aspiration is NOT the Primary Treatment

Hydrosalpinx fluid should NOT be routinely aspirated as a standalone treatment; instead, laparoscopic salpingectomy or proximal tubal occlusion should be performed before IVF to improve pregnancy outcomes. Simple aspiration alone has inferior outcomes compared to definitive surgical management.

The Evidence Against Simple Aspiration

The 2024 network meta-analysis 1 demonstrates that while ultrasound-guided aspiration significantly increases ongoing pregnancy rates compared to no treatment (OR 2.80,95% CI 1.03-7.58), it is inferior to both salpingectomy and laparoscopic tubal occlusion (LTO) for clinical pregnancy outcomes. The recurrence rate after aspiration alone is unacceptably high at 21.7-30.5% 2.

Recommended Surgical Approach

First-Line Options (in order of preference):

1. Laparoscopic Proximal Tubal Occlusion (LTO)

   • Highest SUCRA ranking (0.9) for live birth 1
   • Significantly increases clinical pregnancy rate vs. no treatment (OR 2.55,95% CI 1.20-5.51) 1
   • Less invasive than salpingectomy
   • Preserves ovarian blood supply

2. Laparoscopic Salpingectomy

   • Increases ongoing pregnancy rate (OR 4.35,95% CI 1.70-11.14) 1
   • Increases clinical pregnancy rate (OR 2.24,95% CI 1.30-3.86) 3
   • Definitive treatment with no recurrence
   • Concern: May decrease AMH levels 4, though ovarian response to stimulation remains adequate

Alternative: Sclerotherapy

Hydrosalpinx sclerotherapy (aspiration + sclerosing agent) is superior to aspiration alone and comparable to salpingectomy for pregnancy outcomes 2. The 2024 aggregate analysis 1 shows sclerotherapy significantly increases live birth rates compared to no treatment and has a favorable safety profile regarding ovarian response. This is particularly useful for:

• Women with dense adhesions from previous surgeries
• Bilateral hydrosalpinges where preserving some ovarian blood supply is critical
• Patients who refuse or cannot tolerate laparoscopy

When Aspiration May Be Considered

Ultrasound-guided aspiration during oocyte retrieval has a specific, limited role:

• Only for hydrosalpinx that develops DURING controlled ovarian hyperstimulation 5
• One study showed aspiration of hydrosalpinx occurring during COH significantly improved clinical outcomes (clinical pregnancy rate 38.5% vs 25.26% without intervention) 5
• NOT effective for hydrosalpinx present before COH starts 5

Critical Timing Consideration

Perform tubal surgery BEFORE starting IVF stimulation, not after oocyte retrieval 6. The "Ligation-COH" approach (surgery first, then stimulation) showed:

• Higher clinical pregnancy rate: 55.69% vs 38.5%
• Higher live birth rate: 47.08% vs 25.26%
• Lower miscarriage rate: 10.47% vs 17.20%
• Higher cumulative live birth rate: 69.47% vs 47.47%

Common Pitfalls to Avoid

1. Don't perform simple aspiration alone - recurrence rates are too high (>20%) and pregnancy outcomes inferior
2. Don't delay surgery until after oocyte retrieval - outcomes are significantly worse 6
3. Don't skip treatment entirely - untreated hydrosalpinx decreases implantation and clinical pregnancy rates while increasing ectopic pregnancy and miscarriage rates 4
4. Consider antibiotic prophylaxis if history of PID or hydrosalpinx noted during procedures 7

The Bottom Line

The ACR guidelines 7 emphasize that hydrosalpinx has "implications for patients who may undergo in vitro fertilization" and recommend antibiotic consideration when hydrosalpinx is present. While these imaging guidelines don't specify surgical management, the research evidence overwhelmingly supports definitive surgical intervention (LTO or salpingectomy) over simple aspiration to optimize IVF outcomes and minimize recurrence.